Special Issue "Advances in Nanomaterials for Drug Delivery and Controlled Drug Release"
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 4818
Special Issue Editor
Interests: drug delivery; infectious diseases; nanomedicine; nanotechnology; pharmaceutics; women’s health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanomedicine has gone a long way since its inception as a medicine-related nanotechnology gimmick in the 1990s, and has now seen the successful launch of multiple drug products in the market for diagnostics, imaging, therapy, prophylaxis and regenerative medicine. Among other examples, and likely the most notorious these days, are the COVID-19 mRNA vaccines, which rely on the use of lipid nanoparticles to intracellularly deliver its active payload and induce a protective immune response against SARS-CoV-2. Indeed, the central role that many differently engineered nanomaterials used as carriers play in the outcome of nanomedicines cannot be emphasized enough and is dependent on their ability to target different sites of interest and release incorporated active payloads at adequate rates. Advances in the development and characterization of nanomaterials for medical applications have indeed been tremendous and justify the launching of this Special Issue. As guest editor, I would like to encourage potential contributors to submit their finest research work in the format of full papers or communications, as well as critical reviews, in all aspects pertaining to nanomaterials intended for the delivery and/or controlled release of drugs (small molecules, biopharmaceuticals, contrast agents, etc.), and that could be useful for human or veterinary diagnostics, imaging, therapy, prophylaxis or regenerative medicine.
Dr. José das Neves
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Biomaterials
- Diagnostics
- Drug Products
- Gene Delivery
- Medical Imaging
- Materials Science
- Nanocarriers
- Nanodrugs
- Nanomedicine
- Nanopharmacology
- Nanotechnology
- Nanotherapeutics
- Nanotoxicology
- Disease Prophylaxis
- Regenerative Medicine
- Targeted Therapy
